Up 40%: Is This Red-Hot Growth Stock Still a Buy? [Yahoo! Finance]
Agenus Inc. (AGEN)
Last agenus inc. earnings: 3/12 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
agenusbio.com/investors
Company Research
Source: Yahoo! Finance
The company is set to announce its first-quarter earnings for 2024 before the market opens on Tuesday, May 7. However, there's no certainty that the company will release any information that justifies this significant surge in its shares. So, what's causing all the excitement? Investors seem to believe that the company is approaching a significant turning point. This could be due to its promising anti-cancer combination of the checkpoint inhibitors botensilimab (BOT) and balstilimab (BAL). Agenus intends to apply for approval of this combination for use in later-line metastatic microsatellite stable (MSS) colorectal cancer (CRC) without active liver metastases by mid-year. But the question remains: Is Agenus still a strong speculative buy after its recent rise? Let's dig deeper to find out. Agenus' core value proposition The near-term value proposition of Agenus hinges on the BOT + BAL filing in advanced CRC. Despite being a later-line setting, Agenus stands to gain from a fav
Show less
Read more
Impact Snapshot
Event Time:
AGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGEN alerts
High impacting Agenus Inc. news events
Weekly update
A roundup of the hottest topics
AGEN
News
- HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [Yahoo! Finance]Yahoo! Finance
- Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Agenus (AGEN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Agenus Inc. (NASDAQ: AGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.MarketBeat
- Agenus Reports First Quarter 2024 Results [Yahoo! Finance]Yahoo! Finance
AGEN
Earnings
- 5/7/24 - Beat
AGEN
Sec Filings
- 5/7/24 - Form 4
- 5/7/24 - Form 10-Q
- 5/7/24 - Form 8-K
- AGEN's page on the SEC website